2017-11-06 10:00:00

Invitation to presentation of Recipharm's interim report for the third quarter 2017 on the 9th November


Recipharm will publish its interim report for January-September 2017 on 9 November at 07:45 am CET.

The company invites investors, analysts and media to a web conference (in English) on 9 November at 10:00 am CET, where CEO Thomas Eldered and CFO Henrik Stenqvist will present and comment on the report as well as answer questions.

The report will be available on Recipharm's website www.recipharm.com/investor-relations from 07:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 9 November.

To participate in the web conference, please use the below link:

http://edge.media-server.com/m/p/s9iighaa 

Questions may be submitted by dialing below telephone numbers or by typing them in the Q&A box during the conference. If you don't wish to ask questions by telephone you only need to participate through the link above.

From Sweden: +46 8 566 426 51
From Denmark: +45 354 455 77
From Norway: +47 235 00 243
From the UK: +44 333 300 08 04
From Germany: +49 691 380 34 30
From Switzerland: +41 225 809 034
From France: + 33 170 750 711
From Portugal: +351 210 609 105
From India: +91 226 187 51 27
From Italy: +39 023 601 38 21
From Israel: +972 372 076 79
From the USA: +1 631 913 14 22 

Pin code for participants:
78642485#

For more information, please contact:
ir@recipharm.com,telephone: +46 8 602 52 00



Recipharm AB (publ)

Corporate identity number 556498-8425
Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00
www.recipharm.com


Attached html: HTML
Attached pdf: PDF